Skip to main content
All lobbying filings

DLA PIPER LLP (US)

DLA PIPER LLP (US) filed a Q4 report for INDIVIOR INC. on January 20, 2026, reporting $60,000 in lobbying income.

Lobbying for INDIVIOR INC. · Pharmaceutical company

All filings by DLA PIPER LLP (US) · Everything INDIVIOR INC. has reported

 Filing · LD-2 quarterly report Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Income
$60,000
What the client paid this registrant for the period.
Client based in
Virginia

Official filing document

 Government bodies contacted 1

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2
Medicare/Medicaid

H.R. 2586, Reentry Act of 2025, policies related to reimbursement of substance use disorder treatment.

Health Issues

General education on issues related to the Drug Enforcement Agency (DEA). Issues related to substance use addiction and treatment, including NIH/HHS funding levels.Issues related to access to addiction treatments, including telehealth.

 Bills named in this filing 1

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem